Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mauser

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Health Care Financing Review|April 1, 1997
Medicare Home Health Initiative: current activities and future directionsE Mauser
Health Care Financing Review|March 4, 1995
A profile of home health users in 1992E Mauser, N A Miller
The Gerontologist|February 1, 1996
"The PACE Evaluation": two responsesS B Clauser, D Kidder, E Mauser
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1976
Development of rat mast cells in vitro. I. Differentiation of mast cells from thymus cellsT Ishizaka, H Okudaira, L E Mauser, et al.
Blood|November 1, 1996
A deletion mutation causes hemophilia B in Lhasa Apso dogsA E Mauser, J Whitlark, K M Whitney, et al.
Journal of Virology|July 10, 1999
The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 inductionJ J Swenson, A E Mauser, W K Kaufmann, et al.
Thrombosis and Haemostasis|February 1, 1995
The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliabilityB Verbruggen, I Novakova, H Wessels, et al.
Vox Sanguinis|January 5, 1999
Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patientsG Roosendaal, Y van der Schouw, E Mauser-Bunschoten, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2012
Malignant disease in the haemophilic population: moving towards a management consensus?J Astermark, M Makris, E Mauser-Bunschoten, et al.
Thrombosis and Haemostasis|February 12, 1998
Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitorsY Sawamoto, R Prescott, D Zhong, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Health Care Financing Review|April 1, 1997
Medicare Home Health Initiative: current activities and future directionsE Mauser
Health Care Financing Review|March 4, 1995
A profile of home health users in 1992E Mauser, N A Miller
The Gerontologist|February 1, 1996
"The PACE Evaluation": two responsesS B Clauser, D Kidder, E Mauser
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1976
Development of rat mast cells in vitro. I. Differentiation of mast cells from thymus cellsT Ishizaka, H Okudaira, L E Mauser, et al.
Blood|November 1, 1996
A deletion mutation causes hemophilia B in Lhasa Apso dogsA E Mauser, J Whitlark, K M Whitney, et al.
Journal of Virology|July 10, 1999
The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 inductionJ J Swenson, A E Mauser, W K Kaufmann, et al.
Thrombosis and Haemostasis|February 1, 1995
The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliabilityB Verbruggen, I Novakova, H Wessels, et al.
Vox Sanguinis|January 5, 1999
Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patientsG Roosendaal, Y van der Schouw, E Mauser-Bunschoten, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2012
Malignant disease in the haemophilic population: moving towards a management consensus?J Astermark, M Makris, E Mauser-Bunschoten, et al.
Thrombosis and Haemostasis|February 12, 1998
Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitorsY Sawamoto, R Prescott, D Zhong, et al.
Pageof 2